EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: Possible role in local recurrence

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Abdel Aziz, Azza ^a   Amin, Maha M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Ameloblastoma; CD10; EGFR; Ki67 and recurrence

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; MEMBRANE METALLOENDOPEPTIDASE; TUMOR MARKER;

ADULT; AMELOBLASTOMA; ARTICLE; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; MANDIBLE TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; AMELOBLASTOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; MANDIBULAR NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPRILYSIN; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84856505148     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-14     Document Type: Article

References (39)

1. Melrose R. Benign epithelial odontogenic tumors. Semin Diagn Pathol 2002, 16:271-87.
2. Philipsen H, Reichart P, Nikai H, Takata T, Kudo Y. Peripheral ameloblastoma: biological profile based on 160 cases from the literature. Oral Oncol 2001, 37:17-27. 10.1016/S1368-8375(00)00064-6, 11120479.
3. Regezi J. Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws. Mod Pathol 2001, 15:331-41.
4. Pinheiro J, Freitas V, Moretti A, Jorge AG, Jaeger RG. Local invasiveness of ameloblastoma. Role played by matrix metallo-proteinases and proliferative activity. Histopathology 2004, 45:65-72. 10.1111/j.1365-2559.2004.01902.x, 15228445.
5. Gilijamse M, Leemans CR, Winters HA, Schulten EA, Van der Waal I. Metastasizing ameloblastoma. Int J Oral Maxillofac Surg 2007, 36:462-64. 10.1016/j.ijom.2006.12.005, 17275258.
6. World Health Organization Classification of Tumours. Pathology and Genetics. Head and Neck Tumours 2005, Lyon: IARC Press, Barnes L, Eveson J, Reichart P, Sidransky D.
7. Gardner DG, Heikinheimo K, Shear M, Philipsen HP, Colemen H. ameloblastoma. World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumors 2005, 296. Published by IARCPress Lyon, France, Leon Barnes, John W Eveson, Peter Reichart, David Sidransky.
8. Oda K, Matsuoka Y, Funahashi A, Kitano H. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 2005, 1:2005.010.
9. Sorensen OE, Tapa DR, Roupé KM, Valore EV, Sjobring U, Roberts AA, Schmidtchen A, Ganz T. Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 2006, 116(7):1878-1885. 10.1172/JCI28422, 1479426, 16778986.
10. Baselga J, O'Dwyer PJ, Thor AD, Vokes EE, Weiner LM. Epidermal growth factor receptor: potential target for antitumor agents. 2000, 1-24. Dallas, TX: The Center for Biomedical Continuing Education.
11. Jost M, Kari C, Rodeck U. The EGF receptor--an essential regulator of multiple epidermal functions. Eur J Dermatol 2000, 10:505-10.
12. Agaram NP, Collins BM, Barnes L, Lomago D, Aldeeb D, Swalsky P, Finkelstein S, Hunt JL. Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med 2004, 128:313-7.
13. Goo YA, Goodlett DR, Pascal LE, Worthington KD, Vessella RL, True LD, Liu AY. Stromal mesenchymal cell genes of the human prostate and bladder. BMC Urology 2005, 5:17. 10.1186/1471-2490-5-17, 1327674, 16343351.
14. Huang W, Zhou X, Chen J, Zhang LH, Meng K, Ma HH, Lu ZF. CD10-positive stromal cells in gastric carcinoma: Correlation with invasion and metastasis. Japanese J of Clini Oncol 2005, 35(5):245-50.
15. Kanitakis J, Narvaez D, Claudy A. Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin. Melanoma Res 2002, 12(3):241-4. 10.1097/00008390-200206000-00007, 12140380.
16. O'Leary TJ, Frisman DM. Antigenes. Advanced diagnostic methods in pathology: Principles, practice and protocols Saunders 2003, 35-91. O'Leary TJ, 1.
17. Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y, Ohishi M. Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Oral Oncology 2001, 37:193-198. 10.1016/S1368-8375(00)00079-8, 11167148.
18. Partridge M, Gullick WJ, Langdon JD, Sherriff M. Expression of epidermal growth factor receptor on oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1988, 26:381-9. 10.1016/0266-4356(88)90090-3, 3056511.
19. Vered M, Shohat I, Buchner A. Epidermal growth factor receptor expression in ameloblastoma. Oral Oncol 2003, 39:138-43. 10.1016/S1368-8375(02)00034-9, 12509966.
20. de Vicente JC, Torre-Iturraspe A, Gutiérrez AM, Lequerica-Fernández P. Immunohistochemical comparative study of the odontogenic keratocysts and other odontogenic lesions. Med Oral Patol Oral Cir Bucal 2010, 15(5):e709-15.
21. Iwaya K, Ogawa H, Izumi M, Kuroda M, Kuroda M, Mukai K. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchow Arch 2002, 440:589-93.
22. Zu X, Tang Z, Li Y, Gao N, Din J, Qi L. Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis. BJU Int 2006, 98(5):1090-3. 10.1111/j.1464-410X.2006.06446.x, 17034609.
23. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, Almeida OP, Carrasco-Daza D, Garcia-Vazquez F, Farfan-Morales JE, Irigoyen-Camacho ME, Damián-Matsumura. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol 2008, 44(8):805-11. 10.1016/j.oraloncology.2007.10.007, 18207448.
24. Pinheiro JJ, Freitas VM, Moretti AI, Jorge AG, Jaeger RG. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathol 2004, 45(1):65-72.
25. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med 2004, 350(21):2129-39. 10.1056/NEJMoa040938, 15118073.
26. Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI. ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 2007, 117(8):2051-8. 10.1172/JCI32278, 1934579, 17671639.
27. Kuan CT, Wikstrand CJ, Bigner DD. EGF mutant receptor VIII as a molecular target in cancer therapy. Endocr Relat Cancer 2001, 8(2):83-96. 10.1677/erc.0.0080083, 11397666.
28. Shrestha P, Yamada K, Higashiyama H, Takagi H, Mori M. Epidermal growth factor receptor in odontogenic cysts and tumors. J Oral Pathol Med 1992, 21:314-7. 10.1111/j.1600-0714.1992.tb01018.x, 1522533.
29. Li T, Browne RM, Matthews JB. Expression of epidermal growth factor receptors by odontogenic jaw cysts. Virchows Archiv A Pathol Anat 1993, 423:137-44.
30. Ueno S, Miyagawa T, Kaji R, Mushimoto K, Shirasu R. Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas. J Pathol 1994, 173:33-8. 10.1002/path.1711730106, 7931835.
31. Ogawa H, Iwaya K, Izumi M, Kuroda M, Serizawa H, Koyanagi Y, Mukai K. Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 2002, 33:806-11. 10.1053/hupa.2002.125773, 12203213.
32. Makretzov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod Pathol 2007, 20(1):84-89. 10.1038/modpathol.3800713, 17143263.
33. Piattelli A, Fioroni M, Iezzi G, Perritti V, Stellini E, Piattelli M, Rubini C. CD10 expression in stromal cells of oral cavity squamous cell carcinoma: a clinic and pathologic correlation. Oral Dis 2006, 12:301-4. 10.1111/j.1601-0825.2005.01196.x, 16700740.
34. Freedland SJ, Seligson DB, Liu AY, Pantuck AJ, Paik SH, Horvath S, Wieder JA, Zisman A, Nguyen D, Tso CL, Palotie AV, Belldegrun AS. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate 2003, 55:71-80. 10.1002/pros.10202, 12640663.
35. Lezzi G, Piattelli A, Rubini C, Artese L, Goteri G, Artese L, Goteri G, Fioroni M, Carinci F. CD10 expression in stromal cells of ameloblastoma variants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 105(2):206-9. 10.1016/j.tripleo.2007.05.025, 17942343.
36. Masloub SM, Abdel-Azim AM, Abd Elhamid ES. CD10 and osteopontin expression in dentigerous cyst and ameloblastoma. Diagnostic Pathology 2011, 6:44. 10.1186/1746-1596-6-44, 3118315, 21609487.
37. Sandstad B, Golouh R, Nesland JM, Selak I, Torlakovic EE. CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Modern Pathology 2004, 17:1251-58. 10.1038/modpathol.3800174, 15205682.
38. Tsai ST, Jin YT. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinomas. J Oral Pathol Med 1995, 24:313-5. 10.1111/j.1600-0714.1995.tb01191.x, 7473268.
39. Hirayama T, Hamada T, Hasui K. Immunohistochemical analysis of cell proliferation and suppression of ameloblastoma with special reference to plexiform and follicular ameloblastoma. Acta Histochem Cytochem 2004, 37:391-8.